CTRI/2024/03/063414尚未招募4 期
An open label randomised controlled study to determine the efficacy and safety of topical Ozenoxacin vs Mupirocin vs Fusidic acid in mild to moderate impetigo contagiosa in pediatric age group. - NI
Ranjan Rashmiraj Sahu0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Patients with clinical diagnosis of primary Impetigo.
- •2. Impetigo of mild( < 6 lesion) to moderare(6 to 20 lesion) variety.
- •3. Total affected area at baseline not exceeding 100 cm2 or more than 2% of the
- •4. Age between 2 month to 15 years.
- •5. Skin infection rating score more than equal to four.
- •6. Parent or legal guardian willing to comply with the protocol.
排除标准
- •1.Patient age less than 2 month and more than 15 years.
- •2.Impetigo of severe( >20 lesions)variety and which warrants systemic therapy.
- •3.Hypersensitivity to fusidic acid,mupirocin and ozenoxacin.
- •4.Pre existing eczematous dermatitis with clinical evidence of secondary infection or the presence of a bacterial infection that could not be appropriately treated by a topical antibiotic.
- •5.use of topical or systemic antibiotic or corticosteroids within one week of baseline.
研究者
相似试验
已完成
3 期
ooking for better treatments for impetigo in Aboriginal childreImpetigo in Aboriginal childrenSkin - Other skin conditionsInfection - Other infectious diseasesACTRN12609000858291Menzies School of Health Research660
已完成
不适用
A prospective randomised open label study to determine the best dose escalation scheme of dipyridamol added to acetylsalicylic acid, based on the side-effect headache, in patients starting secondary preventive therapy for strokeCVA / TIA10029305StrokeNL-OMON36298Albert Schweitzer Ziekenhuis114
进行中（未招募）
不适用
A prospective randomised open label study to determine the best dose escalation sceme of dipyridamol added to acetylsalicylic acid, based on the side-effect headache, in patients starting secondary preventive therapy for stroke - DOSE studyStrokeEUCTR2010-022913-25-NL150
进行中（未招募）
不适用
An open label, randomized, controlled study to evaluate the safety and efficacy of aerosolized surfactant, Curosurf®, delivered via nasal continuous positive airway pressure pulmonary drug delivery system (NCPAP PDDS) in infants with respiratory distress syndrome.The medical condition for this application is the Respiratory Distress Syndrome (RDS). RDS, also known as hyaline membrane disease, is characterized by lung immaturity and surfactant deficiency and is the most common respiratory disorder in premature infants. The first clinical manifestations of RDS at birth are grunting respiration, subcostal and intercostal retractions, cyanosis and nasal flaring.EUCTR2005-000489-37-CZektar Therapeutics20
进行中（未招募）
1 期
An open label randomised controlled study to evaluate the induction of immune memory following infant vaccination with a glyco-conjugate Neisseria meningitidis serogroup C vaccine and to assess the immunological impact of administering routine infant immunisations in consistent versus alternating limbs - Can we reduce the number of vaccine injections for children?Active immunisation of children for the prevention of invasive diseases caused by Neisseria meningitidis serogroup C, Streptococcus pneumoniae, diphtheria, tetanus, pertussis, poliomyelitis and invasive infections caused by Haemophilus influenzae type b.MedDRA version: 12.0 Level: LLT Classification code 10028911 Term: Neisseria meningitidis infection NOSMedDRA version: 12.1 Level: LLT Classification code 10042194 Term: Streptococcus pneumoniae meningitisMedDRA version: 12.1 Level: LLT Classification code 10042195 Term: Streptococcus pneumoniae pneumoniaMedDRA version: 12.1 Level: LLT Classification code 10035648 Term: Pneumococcal pneumonia [Streptococcus pneumoniae pneumonia]MedDRA version: 12.1 Level: LLT Classification code 10042197 Term: Streptococcus pneumoniae septicaemiaMedDRA version: 12.1 Level: LLT Classification code 10018952 Term: Haemophilus influenzae infectionMedDRA version: 12.1 Level: LLT Classification code 10018953 Term: Haemophilus influenzae meningitisMedDRA version: 12.1 Level: LLT Classification code 10035680 Term: Pneumonia due to Haemophilus influenzae (H. influenzae)MedDRA version: 12.1 Level: LLT Classification code 10058214 Term: Septicaemia due to haemophilus influenzae (H. influenzae)EUCTR2009-016579-31-GBniversity of Oxford509